Augmented Reality Treadmill Training in Patients With Parkinson's Disease
- Conditions
- FallParkinson Disease
- Interventions
- Device: C-Mill augmented reality treadmill training
- Registration Number
- NCT04108741
- Lead Sponsor
- Klinik Valens
- Brief Summary
Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients during the course. Three methods of treadmill training (TT) will be compared to assess additional augmented reality (AR), or additional dual task (DT). AR TT, DT TT, and TT alone applied over 3 weeks at each day will be compared for their impact on falls, walking, freezing and attention for 3 months in a double blinded randomized controlled trial during regular neurorehabilitation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Informed Consent as documented by signature
- Parkinson´s disease without dementia and hallucination
- at least one fall within the past 3 months or postural instability
- Gait disorder
- Hoehn and Yahr stages II-IV
- able to perform the treadmill therapy during a study
- Contraindications to treadmill therapy (e.g. hip fracture)
- Dementia as defined by an Montreal cognitive assessment (MOCA) < 20
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description treadmill training C-Mill augmented reality treadmill training - treadmill training with augmented reality dual tasking C-Mill augmented reality treadmill training - treadmill training with random number generation dual tasking C-Mill augmented reality treadmill training -
- Primary Outcome Measures
Name Time Method Frequency of falls 3 months before study to 3 months following the study group difference of the difference in falls
- Secondary Outcome Measures
Name Time Method Secondary outcomes: before and after the training period of 3 weeks Freezing of Gait (FOG) Questionnaire
Sensor based gait analyses before and after the training period of 3 weeks and after 3 months for one week
Trial Locations
- Locations (1)
Department of Neurology
🇨🇭Valens, Saint Gallen, Switzerland